INTS vs PODD
Intensity Therapeutics, Inc. Common stock (INTS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
INTS currently screens at market cap $7.7M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the INTS and PODD stock pages for the full models.
Not investment advice.